Clinical Trial Update: Evaluation of Hypoxia by PET With F-Miso in Radiation Therapy of Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating hypoxia imaging using the PET tracer 18F-fluoromisonidazole (F-Miso) in conjunction with radiation therapy for prostate cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• F-Miso (18F-fluoromisonidazole) (18F-fluoromisonidazole)

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Prostate Adenocarcinoma | Phase 2 | Status: COMPLETED